N/A N=30 Randomized Health Services Research

LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound

Dehydration in Children · Dehydration

Bottom Line

View on ClinicalTrials.gov: NCT03712189 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Feb 2021

Primary outcome: Primary: Duration- Ultrasound Ordered to Completed — 154.4; 114.8 minutes

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: LifeFlow (Device)
Age: Pediatric, Adult · 0+ yrs
Sex: Female
Sponsor: Children's Hospital Los Angeles
Primary completion: May 2019

Outcome Measures

Outcome	Result	p-value
PRIMARY Duration- Ultrasound Ordered to Completed	154.4; 114.8	—
SECONDARY Total IV Fluid (mL)	1612.9; 1482.7	—
SECONDARY Duration- Full Bladder	61.9; 26.9	—

Summary

This is an unblinded, randomized control study examining two fluid delivery modalities for non-critical female patients with a planned transabdominal pelvic ultrasound requiring intravenous fluid boluses.

Eligibility Criteria

Inclusion Criteria

Female patients older than 1 month and less than 18 years
Patients require IV crystalloid bolus fluids before a pelvic ultrasound

Exclusion Criteria

Known cardiac insufficiency or significant cardiac surgery
Hepatic insufficiency
Renal insufficiency
Any known fluid overload states (ascites, pulmonary edema)
On any diuretic or antihypertensive therapy
Known pregnancy

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03712189). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.